Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 1997

View Archived Issues

Lipid peroxidation inhibitors from Gyogyszerkutato Intezet

New antibacterial agents described by Zeneca

Astra describes new topical anesthetics

Inhibitors of 5alpha-reductase prepared by Merck & Co.

P&U discloses inhibitors of enzyme involved in neurodegenerative diseases

Thrombin inhibitors revealed by Merck & Co.

Janssen prepares lubelozole N-oxides

BRL-49653: Profile of a potential new antidiabetic agent

BTS-67582 preclinical and clinical trials results

Agent for gastroparesis in diabetic patients

Studies reported on absorption of the insulin analogue HOE-901

New antidiabetic agent from Japan Tobacco

NN-304, a long-acting insulin analogue in preclinical testing

Skelid introduced in the U.S.

Introduction of Rescriptor in late June

Company profile: Trilex

Guilford's Parkinson's disease diagnostic safe and effective in phase IIb study

Micrologix Biotech enhancin restores activity of vancomycin

Synthelabo and Praecis collaborate on prostate cancer product

Peptidomimetic inhibitors of fungal NMT prepared by Searle

Encouraging interim data from Avicidin trial

Protein repair enzyme may be involved in seizures/neurodegenerative diseases

Chugai MSD to market OTC famotidine in Japan

Pfizer terminates E5 marketing agreement

Physostigmine improves working memory and alters neural activity in volunteers

Retinal protein reduces need for standard drugs in uveitis

Eclipse cleared by FDA to begin clinical trials of PTMR

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...